News headlines about Symmetry Medical (NYSE:SMA) have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Symmetry Medical earned a daily sentiment score of 0.05 on Accern’s scale. Accern also assigned news coverage about the healthcare company an impact score of 46.4278545700378 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

ILLEGAL ACTIVITY NOTICE: “Symmetry Medical (SMA) Getting Somewhat Favorable Media Coverage, Report Shows” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/09/21/symmetry-medical-sma-getting-somewhat-favorable-media-coverage-report-shows.html.

About Symmetry Medical

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments).

Insider Buying and Selling by Quarter for Symmetry Medical (NYSE:SMA)

Receive News & Stock Ratings for Symmetry Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symmetry Medical Inc. and related stocks with our FREE daily email newsletter.